332 related articles for article (PubMed ID: 8171003)
1. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts.
Adams M; Sharmeen L; Kimpton J; Romeo JM; Garcia JV; Peterlin BM; Groudine M; Emerman M
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3862-6. PubMed ID: 8171003
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.
Unwalla H; Banerjea AC
Biochem J; 2001 Jul; 357(Pt 1):147-55. PubMed ID: 11415445
[TBL] [Abstract][Full Text] [Related]
3. A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.
Benko DM; Schwartz S; Pavlakis GN; Felber BK
J Virol; 1990 Jun; 64(6):2505-18. PubMed ID: 2186172
[TBL] [Abstract][Full Text] [Related]
4. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
Natarajan V; Radjendirane V; Salzman NP
Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
[TBL] [Abstract][Full Text] [Related]
5. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes.
Tornatore C; Meyers K; Atwood W; Conant K; Major E
J Virol; 1994 Jan; 68(1):93-102. PubMed ID: 8254781
[TBL] [Abstract][Full Text] [Related]
6. Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes.
Willard-Gallo KE; Furtado M; Burny A; Wolinsky SM
Eur J Immunol; 2001 Apr; 31(4):969-79. PubMed ID: 11298321
[TBL] [Abstract][Full Text] [Related]
7. High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants.
Chanda PK; Natuk RJ; Mason BB; Bhat BM; Greenberg L; Dheer SK; Molnar-Kimber KL; Mizutani S; Lubeck MD; Davis AR
Virology; 1990 Apr; 175(2):535-47. PubMed ID: 2183470
[TBL] [Abstract][Full Text] [Related]
8. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.
Lassen KG; Ramyar KX; Bailey JR; Zhou Y; Siliciano RF
PLoS Pathog; 2006 Jul; 2(7):e68. PubMed ID: 16839202
[TBL] [Abstract][Full Text] [Related]
9. The tat gene and protein of the human immunodeficiency virus type 1.
Caputo A; Grossi MP; Rossi C; Campioni D; Balboni PG; Corallini A; Barbanti-Brodano G
New Microbiol; 1995 Jan; 18(1):87-110. PubMed ID: 7760763
[No Abstract] [Full Text] [Related]
10. Evidence for CTL-mediated selection of Tat and Rev mutants after the onset of the asymptomatic period during HIV type 1 infection.
Guillon C; Stankovic K; Ataman-Onal Y; Biron F; Verrier B
AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1283-92. PubMed ID: 17209772
[TBL] [Abstract][Full Text] [Related]
11. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
Liem SE; Ramezani A; Li X; Joshi S
Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator.
Bevec D; Dobrovnik M; Hauber J; Böhnlein E
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9870-4. PubMed ID: 1409715
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection.
Graziosi C; Pantaleo G; Butini L; Demarest JF; Saag MS; Shaw GM; Fauci AS
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6405-9. PubMed ID: 8341646
[TBL] [Abstract][Full Text] [Related]
14. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference.
Coburn GA; Cullen BR
J Virol; 2002 Sep; 76(18):9225-31. PubMed ID: 12186906
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
Ulich C; Harrich D; Estes P; Gaynor RB
J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
[TBL] [Abstract][Full Text] [Related]
16. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.
Robert-Guroff M; Popovic M; Gartner S; Markham P; Gallo RC; Reitz MS
J Virol; 1990 Jul; 64(7):3391-8. PubMed ID: 2191150
[TBL] [Abstract][Full Text] [Related]
17. The HIV-1 transactivator protein Tat is a potent inducer of the human DNA repair enzyme beta-polymerase.
Srivastava DK; Tendler CL; Milani D; English MA; Licht JD; Wilson SH
AIDS; 2001 Mar; 15(4):433-40. PubMed ID: 11242139
[TBL] [Abstract][Full Text] [Related]
18. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
[TBL] [Abstract][Full Text] [Related]
19. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
20. Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells.
Duan L; Oakes JW; Ferraro A; Bagasra O; Pomerantz RJ
Virology; 1994 Mar; 199(2):474-8. PubMed ID: 8122376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
